GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Modeyso® | ONC-201 | ONC201 | TIC-10 | TIC10
dordaviprone is an approved drug
Compound class:
Synthetic organic
Comment: Dordaviprone (ONC201, also known as TIC10 [2]) was originally discovered as a TRAIL pathway inducer and as an orally active dual Akt/ERK inhibitor [1]. It exerts potent anti-tumour effects [6,10-11].
ONC201 was later reported as an allosteric activator of the oncology drug target, mitochondrial protease caseinolytic protease P (ClpP) [4-5,9]. It also antagonises dopamine D2/3 receptor signalling [7-8]. |
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. US FDA (2025) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 12147 | dordaviprone |
Synonyms ![]() |
| Modeyso® | ONC-201 | ONC201 | TIC-10 | TIC10 |
Database Links ![]() |
|
| BindingDB Ligand | 50606048 |
| CAS Registry No. | 1616632-77-9 (source: WHO INN record) |
| ChEMBL Ligand | CHEMBL4297310 |
| DrugBank Ligand | DB14844 |
| GtoPdb PubChem SID | 374883865 |
| PubChem CID | 73777259 |
| Search Google for chemical match using the InChIKey | VLULRUCCHYVXOH-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | VLULRUCCHYVXOH |
| Search PubMed clinical trials | dordaviprone |
| Search PubMed titles | dordaviprone |
| Search PubMed titles/abstracts | dordaviprone |
| UniChem Compound Search for chemical match using the InChIKey | VLULRUCCHYVXOH-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | VLULRUCCHYVXOH-UHFFFAOYSA-N |